AP2000002019A0 - Novel formulation containing paroxetine. - Google Patents

Novel formulation containing paroxetine.

Info

Publication number
AP2000002019A0
AP2000002019A0 APAP/P/2000/002019A AP2000002019A AP2000002019A0 AP 2000002019 A0 AP2000002019 A0 AP 2000002019A0 AP 2000002019 A AP2000002019 A AP 2000002019A AP 2000002019 A0 AP2000002019 A0 AP 2000002019A0
Authority
AP
ARIPO
Prior art keywords
formulation containing
novel formulation
containing paroxetine
paroxetine
hemihydrate
Prior art date
Application number
APAP/P/2000/002019A
Inventor
David Philip Elder
Graham Stanley Leonard
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of AP2000002019A0 publication Critical patent/AP2000002019A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Paroxetine hydrochloride, in a form other than the hemihydrate, which is formulated into tablets under conditions such that there is no detectable conversion to hemihydrate during the tabletting process.
APAP/P/2000/002019A 1998-05-13 1999-05-13 Novel formulation containing paroxetine. AP2000002019A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9810181.9A GB9810181D0 (en) 1998-05-13 1998-05-13 Novel formulations
PCT/GB1999/001520 WO1999058113A2 (en) 1998-05-13 1999-05-13 Novel formulation containing paroxetine

Publications (1)

Publication Number Publication Date
AP2000002019A0 true AP2000002019A0 (en) 2000-12-31

Family

ID=10831927

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/2000/002019A AP2000002019A0 (en) 1998-05-13 1999-05-13 Novel formulation containing paroxetine.

Country Status (20)

Country Link
EP (1) EP1077682A2 (en)
JP (1) JP2002514591A (en)
KR (1) KR20010043574A (en)
CN (1) CN1308521A (en)
AP (1) AP2000002019A0 (en)
AU (1) AU3940999A (en)
BG (1) BG105010A (en)
BR (1) BR9910401A (en)
CA (1) CA2331871A1 (en)
EA (1) EA200001174A1 (en)
GB (1) GB9810181D0 (en)
HU (1) HUP0102064A2 (en)
ID (1) ID28019A (en)
IL (1) IL139594A0 (en)
NO (1) NO20005683L (en)
PL (1) PL344573A1 (en)
SK (1) SK17142000A3 (en)
TR (1) TR200003350T2 (en)
WO (1) WO1999058113A2 (en)
ZA (1) ZA200006562B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0003232D0 (en) * 2000-02-11 2000-04-05 Smithkline Beecham Plc Novel composition
CA2359812C (en) 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
ES2230516T3 (en) * 2001-10-22 2005-05-01 Synthon B.V. N-FORMULATED PAROXETINE DERIVATIVES.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9325644D0 (en) * 1993-12-15 1994-02-16 Smithkline Beecham Plc Novel formulation
US5672612A (en) * 1996-09-09 1997-09-30 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
CN1249686A (en) * 1997-01-15 2000-04-05 史密丝克莱恩比彻姆有限公司 Paroxetine compositions
NZ505123A (en) * 1997-12-19 2003-07-25 Smithkline Beecham Corp Process for manufacturing bite-dispersion tablets by compressing medicaments and other ingredients into granulates then compressing the granulates and other ingredients into tablets, and the tablets thereof

Also Published As

Publication number Publication date
NO20005683D0 (en) 2000-11-10
CA2331871A1 (en) 1999-11-18
WO1999058113A3 (en) 2000-02-17
TR200003350T2 (en) 2001-03-21
PL344573A1 (en) 2001-11-05
WO1999058113A2 (en) 1999-11-18
JP2002514591A (en) 2002-05-21
IL139594A0 (en) 2002-02-10
EP1077682A2 (en) 2001-02-28
KR20010043574A (en) 2001-05-25
NO20005683L (en) 2000-12-05
AU3940999A (en) 1999-11-29
BG105010A (en) 2001-07-31
GB9810181D0 (en) 1998-07-08
CN1308521A (en) 2001-08-15
EA200001174A1 (en) 2001-06-25
BR9910401A (en) 2001-01-09
ID28019A (en) 2001-05-03
ZA200006562B (en) 2002-02-13
HUP0102064A2 (en) 2002-05-29
SK17142000A3 (en) 2001-06-11

Similar Documents

Publication Publication Date Title
NZ507271A (en) Fast disintegrating tablets
MY135183A (en) Rapidly disintegrating methylcellulose tablets
HU227841B1 (en) 2-phenyl substituted imidazotriazinones, process for their preparation and pharmaceutical compositions thereof
MY112123A (en) Process for preparing tablets containing paroxetine
MXPA02006826A (en) Cell division inhibitors and process for producing the same.
MX9700273A (en) Substituted benzamidines, their production and their use as medicaments.
MX9801890A (en) Novel human nk3 receptor-selective antagonist compounds, method for obtaining them and pharmaceutical compositions containing them.
HK1030604A1 (en) Method for the synthesis of huperzine a and analogs thereof and compounds useful therein
ZA200100864B (en) Piperidine-4-sulphonamides compounds, a process for their preparation and pharmaceutical compositions containing them.
CA2433366A1 (en) Amlodipine free base
AP2000001985A0 (en) Novel formulation containing paroxetine.
AP2000002019A0 (en) Novel formulation containing paroxetine.
WO2000055287A3 (en) Perfumed detergent tablet
MXPA01012896A (en) New metalloprotease inhibitors, a process for their preparation and pharmaceutical compositions containing them.
PL352104A1 (en) Oral composition containing perlite
EP1044394A4 (en) Process for preparing a radiation-sensitive composition
HK1051845A1 (en) Substituted 1 and 2 naphthol mannich bases
HU0105328D0 (en) Novel bicyclic amino-pirazinone compounds, a process for their preparation and pharmaceutical compositions containing them
IL148161A0 (en) Process for the preparation of 2-cyanopyridines
DK1014789T3 (en) Pressed chloramine T tablets and process for their preparation
MXPA04004980A (en) Ccr-3 receptor antagonists vii.
TW344650B (en) Fungicidal compositions and the process for the preparation thereof
HUP0302620A3 (en) Novel pharmaceutical compositions having an antidiabetic action, and process for their preparation
ZA200103065B (en) Heterocycloalkylbenzocyclobutane and heteroarylbenzocyclobutane compounds, a process for their preparation and pharmaceutical compositions containing them.
ZA200103064B (en) Cyclobutaindolecarboxamide compounds, a process for their preparation and pharmaceutical compositions containing them.